What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Disease
His primary areas of study are Transplantation, Internal medicine, Surgery, Immunology and Hematopoietic stem cell transplantation.
Gérard Socié has included themes like Aplastic anemia, Cyclophosphamide, Anemia, Histocompatibility and Acute leukemia in his Transplantation study.
His research in Internal medicine intersects with topics in Gastroenterology and Oncology.
His Surgery research includes themes of Incidence, Cumulative incidence and Hazard ratio.
He regularly links together related areas like Stem cell in his Immunology studies.
His research integrates issues of Cancer, Hematopoietic cell, Transplantation Conditioning, Fludarabine and Cohort in his study of Hematopoietic stem cell transplantation.
His most cited work include:
- Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia (959 citations)
- The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria (845 citations)
- Solid Cancers after Bone Marrow Transplantation (763 citations)
What are the main themes of his work throughout his whole career to date?
Gérard Socié spends much of his time researching Internal medicine, Transplantation, Hematopoietic stem cell transplantation, Surgery and Immunology.
His Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology and Oncology.
His studies in Gastroenterology integrate themes in fields like Cyclophosphamide and Eculizumab.
He usually deals with Transplantation and limits it to topics linked to Stem cell and Hematology.
In his study, which falls under the umbrella issue of Hematopoietic stem cell transplantation, Busulfan is strongly linked to Regimen.
The various areas that he examines in his Surgery study include Aplastic anemia and Cohort.
He most often published in these fields:
- Internal medicine (71.71%)
- Transplantation (64.64%)
- Hematopoietic stem cell transplantation (46.27%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (71.71%)
- Transplantation (64.64%)
- Oncology (23.08%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Internal medicine, Transplantation, Oncology, Hematopoietic stem cell transplantation and Graft-versus-host disease.
His research in Internal medicine tackles topics such as Gastroenterology which are related to areas like Cumulative incidence.
Within one scientific family, he focuses on topics pertaining to Stem cell under Transplantation, and may sometimes address concerns connected to Cancer research.
In his research, Confidence interval is intimately related to Cohort, which falls under the overarching field of Oncology.
His work carried out in the field of Hematopoietic stem cell transplantation brings together such families of science as Hematology, Human leukocyte antigen and Myelofibrosis.
The Graft-versus-host disease study combines topics in areas such as Immunology, Bone marrow, Anti-thymocyte globulin and Calcineurin.
Between 2017 and 2021, his most popular works were:
- Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells (99 citations)
- A landscape of germ line mutations in a cohort of inherited bone marrow failure patients (98 citations)
- A landscape of germ line mutations in a cohort of inherited bone marrow failure patients (98 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Disease
His main research concerns Internal medicine, Transplantation, Oncology, Hematopoietic stem cell transplantation and Gastroenterology.
His Transplantation research is multidisciplinary, incorporating elements of Total body irradiation, Cyclophosphamide and Cohort.
His Oncology study incorporates themes from Cancer, Haematopoiesis, Stem cell and Risk factor.
His Hematopoietic stem cell transplantation study combines topics in areas such as Myelofibrosis and Metabolomics.
His Gastroenterology research integrates issues from Aplastic anemia, Immunosuppression, Tacrolimus, Cumulative incidence and Proportional hazards model.
His Graft-versus-host disease research incorporates elements of Calcineurin, Immune system, Immunology, Bone marrow and Receptor.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
